nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive Cellular Therapy using Cells Enriched for NKG2D+CD3+CD8+T Cells after Autologous Transplantation for Myeloma
|
Meehan, Kenneth R. |
|
2013 |
19 |
1 |
p. 129-137 9 p. |
artikel |
2 |
Allogeneic Stem Cell Transplantation for Relapsed or Refractory Lymphoma after Conditioning with BEAM/Fludarabine/TBI
|
O’Meara, Alix |
|
2013 |
19 |
1 |
p. 82-86 5 p. |
artikel |
3 |
Allogeneic Transplantation: When is a Mismatch Better than a Match?
|
Shaw, Bronwen E. |
|
2013 |
19 |
1 |
p. 1-2 2 p. |
artikel |
4 |
A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation
|
Karras, Nicole A. |
|
2013 |
19 |
1 |
p. 109-116 8 p. |
artikel |
5 |
Bacteremia in Blood or Marrow Transplantation Patients: Clinical Risk Factors for Infection and Emerging Antibiotic Resistance
|
Bock, Allison M. |
|
2013 |
19 |
1 |
p. 102-108 7 p. |
artikel |
6 |
Correlation of Infused CD3+CD8+ Cells with Single-Donor Dominance after Double-Unit Cord Blood Transplantation
|
Milano, Filippo |
|
2013 |
19 |
1 |
p. 156-160 5 p. |
artikel |
7 |
Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization
|
Micallef, Ivana N.M. |
|
2013 |
19 |
1 |
p. 87-93 7 p. |
artikel |
8 |
Editorial Board
|
|
|
2013 |
19 |
1 |
p. A3- 1 p. |
artikel |
9 |
Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid Treatment
|
Dietrich, Sascha |
|
2013 |
19 |
1 |
p. 22-27 6 p. |
artikel |
10 |
Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative
|
Denzen, Ellen M. |
|
2013 |
19 |
1 |
p. 4-11 8 p. |
artikel |
11 |
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host-Disease
|
Tawara, Isao |
|
2013 |
19 |
1 |
p. 164-168 5 p. |
artikel |
12 |
Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach
|
Blanes, Margarita |
|
2013 |
19 |
1 |
p. 69-74 6 p. |
artikel |
13 |
Long-Term Follow-Up of the Imatinib GRAAPH-2003 Study in Newly Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A GRAALL Study
|
Tanguy-Schmidt, Aline |
|
2013 |
19 |
1 |
p. 150-155 6 p. |
artikel |
14 |
Masthead (Purpose and Scope)
|
|
|
2013 |
19 |
1 |
p. A2- 1 p. |
artikel |
15 |
Officers and Directors of ASBMT
|
|
|
2013 |
19 |
1 |
p. A4- 1 p. |
artikel |
16 |
Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma
|
Vose, Julie M. |
|
2013 |
19 |
1 |
p. 123-128 6 p. |
artikel |
17 |
Preventing Acute Leukemia Relapse after Allogeneic Transplants: How to Move Forward?
|
Rosko, Ashley |
|
2013 |
19 |
1 |
p. 2-3 2 p. |
artikel |
18 |
Prevention of Acute Graft-versus-Host Disease in a Xenogeneic SCID Mouse Model by the Humanized Anti-CD74 Antagonistic Antibody Milatuzumab
|
Chen, Xiaochuan |
|
2013 |
19 |
1 |
p. 28-39 12 p. |
artikel |
19 |
Single Cord Blood Combined with HLA-Mismatched Third Party Donor Cells: Comparable Results to Matched Unrelated Donor Transplantation in High-Risk Patients with Hematologic Disorders
|
Kwon, Mi |
|
2013 |
19 |
1 |
p. 143-149 7 p. |
artikel |
20 |
Survival Differences between Adolescents/Young Adults and Children with B Precursor Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplantation
|
Burke, Michael J. |
|
2013 |
19 |
1 |
p. 138-142 5 p. |
artikel |
21 |
Table of Contents
|
|
|
2013 |
19 |
1 |
p. A5-A8 nvt p. |
artikel |
22 |
Timeline, Epidemiology, and Risk Factors for Bacterial, Fungal, and Viral Infections in Children and Adolescents after Allogeneic Hematopoietic Stem Cell Transplantation
|
Srinivasan, Ashok |
|
2013 |
19 |
1 |
p. 94-101 8 p. |
artikel |
23 |
Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
|
Raiola, Anna Maria |
|
2013 |
19 |
1 |
p. 117-122 6 p. |
artikel |